Cargill Dow LLC
|
Link ID |
131588 |
Title |
Cargill Dow LLC |
Url |
http://www.cargilldow.com/ingeo/home.asp |
Description |
USA. Developers and manufacturers of naturally flame-retardent and biodegradable polylactide fibers for textile and nonwovens processes, from corn starch. Technical documents on PDF files. Consumer and trade information. News archive and press materials. |
Category |
|
Keywords |
|
Date |
Jul 19, 2006 |
Contact Name |
|
Email |
|
Add to My Favorite
Refer it to Friend
Report Broken Link
|
Other links at |
1. |
Frana Polifibre SpA
|
|
Italy. White, semi-dull or solid dyed polyester and polypropylene staple fiber for the textile and nonwovens industries. Also, custom manufacture of plaids and blankets. Technical specifications. English and Italian.
|
2. |
Synthetic Industries Corp
|
|
USA. Manufacturers of polypropylene fibrilated and steel fibers for concrete reinforcement applications. Also, fiber dispensing systems. Extensive technical information on PDF files. Product selection guide. Links to related sites.
|
3. |
Dragon Bioscience Co.,Ltd
|
|
China. Research, development and manufacture of biotechnical Chitosan related textiles. Pure Chitosan fibers (PCF), and Chitosan incorporated (FCP) polyester, acrylic and viscose fibers for yarn spinning. Also, woven fabrics and ready-made garments. Technical information. English and Chinese.
|
4. |
Domo International
|
|
Belgium. Multi-national manufacturing company, active in chemical and polymers, man-made fiber, industrial yarns and floorcoverings. Solution dyed polypropylene and polyamide staple fiber for spinning and nonwovens. Also, solution dyed yarns for weaving and knitting. Detailed technical specifications. Electronic data interchange (EDI). On-line job offerings. English, Dutch, French and German.
|
5. |
Palmetto Synthetics, LLC
|
|
USA. Manufacturers of raw white and solution dyed staple fiber and tow for yarn spinning and nonwovens production, from virgin and recycled polyester, polyamide and various other polymers. Custom specialty treatment capabilities.
|
|
|